AYTU · Categories · Form 4
AYTU - SEC Form 4 insider transactions
Aytu BioPharma Inc. (AYTU) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for AYTU
- Chief Commercial Officer Pyszczymuka Greg was granted 12,500 shares, increasing direct ownership by 53% to 36,102 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Business Officer Disbrow Jarrett was granted 32,106 shares, increasing direct ownership by 109% to 61,568 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Financial Officer Selhorn Ryan J was granted 33,743 shares, increasing direct ownership by 211% to 49,743 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Executive Officer Disbrow Joshua R. was granted 53,946 shares, increasing direct ownership by 35% to 207,203 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Liu Vivian H was granted 10,000 shares, increasing direct ownership by 102% to 19,825 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Jain Abhinav was granted 10,000 shares, increasing direct ownership by 105% to 19,500 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Dockery Carl was granted 10,000 shares, increasing direct ownership by 96% to 20,440 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Donofrio John Jr. was granted 10,000 shares, increasing direct ownership by 266% to 13,762 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Large owner Nantahala Capital Management, Llc4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Commercial Officer Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.89% to 23,602 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Financial Officer Selhorn Ryan J converted options into 105 shares, increasing direct ownership by 0.66% to 16,000 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Commercial Officer Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.90% to 23,393 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Financial Officer Selhorn Ryan J was granted 14,000 shares, increasing direct ownership by 739% to 15,895 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Dockery Carl was granted 1,500 shares, increasing direct ownership by 17% to 10,440 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Donofrio John Jr. was granted 1,500 shares (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Jain Abhinav was granted 1,500 shares, increasing direct ownership by 19% to 9,500 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Disbrow Joshua R.4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Chief Business Officer Disbrow Jarrett4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Director Liu Vivian H was granted 1,500 shares, increasing direct ownership by 18% to 9,825 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Amendment: Director Liu Vivian H was granted 1,500 shares, increasing direct ownership by 22% to 8,325 units (SEC Form 4)4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Pyszczymuka Greg4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Commercial Officer Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.91% to 23,185 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Chief Commercial Officer Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.91% to 22,976 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Large owner Nantahala Capital Management, Llc4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.92% to 22,768 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Pyszczymuka Greg converted options into 209 shares, increasing direct ownership by 0.94% to 22,560 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- Pyszczymuka Greg converted options into 208 shares, increasing direct ownership by 0.94% to 22,351 units (SEC Form 4)4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Jain Abhinav was granted 6,500 shares, increasing direct ownership by 433% to 8,000 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Disbrow Jarrett4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Jain Abhinav was granted 1,500 shares4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Liu Vivian H was granted 1,500 shares, increasing direct ownership by 440% to 1,841 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Donofrio John Jr. was granted 1,500 shares, increasing direct ownership by 197% to 2,262 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Dockery Carl was granted 1,500 shares, increasing direct ownership by 20% to 8,940 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Disbrow Joshua R.4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Brooke Christopher4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Oki Mark K4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Pyszczymuka Greg4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Pyszczymuka Greg4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Pyszczymuka Greg4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Pyszczymuka Greg4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by Disbrow Joshua R.4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Liu Vivian H was granted 6,500 shares, increasing direct ownership by 2,000% to 6,825 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Donofrio John Jr. returned 187,804 shares to the company, decreasing direct ownership by 92% to 15,267 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Cantrell Gary returned 40,000 shares to the company, decreasing direct ownership by 20% to 164,089 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Disbrow Joshua R. returned 80,000 shares to the company, decreasing direct ownership by 6% to 1,151,877 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Dockery Carl returned 40,000 shares to the company, decreasing direct ownership by 21% to 148,805 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Disbrow Joshua R. bought $25,047 worth of shares (112,371 units at $0.22), increasing direct ownership by 10% to 1,231,877 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Pyszczymuka Greg bought $24,480 worth of shares (100,000 units at $0.24), increasing direct ownership by 122% to 182,056 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Disbrow Joshua R. bought $52,614 worth of shares (222,000 units at $0.24), increasing direct ownership by 25% to 1,119,506 units (Amendment)4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Oki Mark K bought $20,700 worth of shares (90,000 units at $0.23), increasing direct ownership by 90% to 190,000 units (Amendment)4/A - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Disbrow Joshua R. was granted 222,000 shares, increasing direct ownership by 25% to 1,119,506 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Oki Mark K was granted 90,000 shares, increasing direct ownership by 90% to 190,000 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Liu Vivian H was granted 6,500 shares4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Oki Mark K was granted 100,000 shares4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4 filed by ARMISTICE CAPITAL, LLC4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: DOCKERY CARL was granted 187,804 units of Common Stock, increasing direct ownership by 18,762% to 188,805 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: MACALUSO MICHAEL was granted 187,804 units of Common Stock, increasing direct ownership by 926% to 208,079 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Donofrio John Jr. was granted 187,804 units of Common Stock, increasing direct ownership by 1,230% to 203,071 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Cantrell Gary was granted 187,804 units of Common Stock, increasing direct ownership by 1,153% to 204,089 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)
- SEC Form 4: Disbrow Joshua R. was granted 800,000 units of Common Stock, increasing direct ownership by 820% to 897,506 units4 - AYTU BIOPHARMA, INC (0001385818) (Issuer)